Catumaxomab versus catumaxomab plus prednisolone in patients with malignant ascites due to epithelial cancer: results from the CASIMAS study

被引：0

作者：

Lordick, F. ^{[1
]}

Wimberger, P. ^{[2
]}

Vergote, I ^{[3
]}

Rosenberg, P. ^{[4
]}

Schneeweiss, A. ^{[5
]}

Bokemeyer, C. ^{[6
]}

Salat, C. ^{[7
]}

Scambia, G. ^{[8
]}

Berton-Rigaud, D. ^{[9
]}

Siena, S. ^{[10
]}

Santoro, A. ^{[11
]}

Cervantes-Ruiperez, A. ^{[12
]}

Guastalla, J. P. ^{[13
]}

Tournigand, C. ^{[14
]}

Colombo, N. ^{[15
]}

Dudnitchenko, A. S. ^{[16
]}

Bondar, V ^{[17
]}

Westermann, A. M. ^{[18
]}

Sehouli, J. ^{[19
]}

机构：

[1] Hamatol & Onkol Klinikum, Med Klin 3, Braunschweig, Germany

[2] Klin Gynakol & Geburtshilfe, Essen, Germany

[3] Univ Ziekenhuizen, Louvain, Belgium

[4] Univ Hosp Linkoping Onkol, Linkoping, Sweden

[5] NCT, Heidelberg, Germany

[6] Univ Klinikum Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Univ Canc Ctr Hamburg, Hamburg, Germany

[7] Hamatoonkol Schwerpunktpraxis, Munich, Germany

[8] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy

[9] Ctr Rene Gauducheau, St Herblain, France

[10] Osped Niguarda Ca Granda, Milan, Italy

[11] Ist Clin Humanitas, Milan, Italy

[12] Univ Valencia, Dept Hematol & Med Oncol, INCLIVA, Valencia, Spain

[13] Ctr Leon Berard, F-69373 Lyon, France

[14] Hop St Antoine, F-75571 Paris, France

[15] Ist Europeo Oncol, Milan, Italy

[16] Kharkiv Oblast Oncol Dispensary Khrarkiv Med Acad, Kharkov, Ukraine

[17] Donetsk Reg Antitumor Ctr, Donetsk, Ukraine

[18] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[19] Univ Klinikum Charite, Berlin, Germany

来源：

ONKOLOGIE | 2012年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：63 / 63

页数：1

共 50 条

[1] CATUMAXOMAB VERSUS CATUMAXOMAB PLUS PREDNISOLONE IN PATIENTS WITH MALIGNANT ASCITES DUE TO EPITHELIAL CANCER: RESULTS FROM THE CASIMAS STUDY
Sehouli, J.
Wimberger, P.
Vergote, I. B.
Rosenberg, P.
Schneeweiss, A.
Bokemeyer, C.
Salat, C.
Scambia, G.
Berton-Rigaud, D.
Lordick, F.
ANNALS OF ONCOLOGY, 2012, 23 : 539 - 539
[2] Catumaxomab with and without prednisolone in patients with malignant ascites due to epithelial cancer: Results from the phase IIIb CASIMAS study
Sehouli, Jalid
Wimberger, Pauline
Vergote, Ignace B.
Rosenberg, Per
Schneeweiss, Andreas
Bokemeyer, Carsten
Salat, Christoph
Scambia, Giovanni
Berton-Rigaud, Dominique
Siena, Salvatore
Santoro, Armando
Cervantes-Ruiperez, Andres
Guastalla, Jean Paul
Tournigand, Christophe
Colombo, Nicoletta
Dudnitchenko, Alexander Serg
Bondar, Vladimir
Westermann, A. M.
Lordick, Florian
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[3] Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study
Sehouli, Jalid
Pietzner, Klaus
Wimberger, Pauline
Vergote, Ignace
Rosenberg, Per
Schneeweiss, Andreas
Bokemeyer, Carsten
Salat, Christoph
Scambia, Giovanni
Berton-Rigaud, Dominique
Santoro, Armando
Cervantes, Andres
Tredan, Olivier
Tournigand, Christophe
Colombo, Nicoletta
Dudnichenko, Alexander S.
Westermann, Anneke
Friccius-Quecke, Hilke
Lordick, Florian
MEDICAL ONCOLOGY, 2014, 31 (08)
[4] Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study
Jalid Sehouli
Klaus Pietzner
Pauline Wimberger
Ignace Vergote
Per Rosenberg
Andreas Schneeweiss
Carsten Bokemeyer
Christoph Salat
Giovanni Scambia
Dominique Berton-Rigaud
Armando Santoro
Andrés Cervantes
Olivier Trédan
Christophe Tournigand
Nicoletta Colombo
Alexander S. Dudnichenko
Anneke Westermann
Hilke Friccius-Quecke
Florian Lordick
Medical Oncology, 2014, 31
[5] Quality of life in patients with malignant ascites during catumaxomab treatment: Results from the CASIMAS trial
Lordick, Florian
Sehouli, Jalid
Vergote, Ignace B.
Rosenberg, Per
Schneeweiss, Andreas
Block, Andreas
Salat, Christoph
Scambia, Giovanni
Berton-Rigaud, Dominique
Siena, Salvatore
Santoro, Armando
Cervantes-Ruiperez, Andres
Guastalla, Jean Paul
Tournigand, Christophe
Colombo, Nicoletta
Dudnitchenko, Alexander Serg
Bondar, Vladimir
Westermann, A. M.
Gonschior, Ann-Katrin
Wimberger, Pauline
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[6] Catumaxomab: Pharmacodynamic and pharmacokinetic data from phase IIIb CASIMAS study in patients with malignant ascites.
Rosenberg, Per
Dudnitchenko, Alexander Serg
Bondar, Vladimir
Salat, Christoph
Havsteen, Hanne
Bokemeyer, Carsten
Berton-Rigaud, Dominique
Durando, Xavier
Vergote, Ignace B.
Wimberger, Pauline
Lordick, Florian
Lindhofer, Horst
Martinius, Holger
Sehouli, Jalid
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[7] Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study
Pietzner, Klaus
Vergote, Ignace
Santoro, Armando
Chekerov, Radoslav
Marme, Frederik
Rosenberg, Per
Martinius, Holger
Friccius-Quecke, Hilke
Sehouli, Jalid
MEDICAL ONCOLOGY, 2014, 31 (12) : 1 - 8
[8] Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
Schmalfeldt, B.
Seck, K.
Gonschior, A. K.
Gilet, H.
Heiss, M.
Hennig, M.
Moehler, M.
Schulze, E.
Wimberger, P.
Parsons, S. L.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
[9] Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone
Gonschior, A.
Gilet, H.
Heisss, M. M.
Hennig, M.
Moehler, M.
Schmalfeldt, B.
Schulze, E.
Wimberger, P.
Parsons, S. L.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S223 - S223
[10] SECOND CYCLE OF CATUMAXOMAB TREATMENT IN PATIENTS WITH MALIGNANT ASCITES: RESULTS FROM THE SECIMAS STUDY
Oskay-Oezcelik, G.
Vergote, I. B.
Santoro, A.
Marme, F.
Rosenberg, P.
Sehouli, J.
ANNALS OF ONCOLOGY, 2012, 23 : 172 - 173

← 1 2 3 4 5 →